Sun Pharma, Ranbaxy rise after regulatory nods for merger deal
At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.
Mar 24, 2015, 17:33 PM IST
Sun Pharma, Ranbaxy rise after regulatory nods for merger deal
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories today settled in the positive territory after regulatory nods paved the way for completion of their USD 4-billion merger.
Mar 24, 2015, 17:20 PM IST
Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments
The central bank also approved issue of equity shares of Sun Pharma to the non-resident holders of equity shares of Ranbaxy Laboratories, the filing added.
Mar 24, 2015, 13:55 PM IST
Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands
Sun Pharma and Ranbaxy have got approval from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their USD 4-billion merger.
Mar 23, 2015, 20:08 PM IST
Sun Pharma pips SBI in market cap; becomes 8th most valued
Drugmaker Sun Pharma on Tuesday surpassed top lender SBI in terms of market capitalisation, becoming the eight most valued listed company in the country.
Mar 17, 2015, 19:03 PM IST
Ranbaxy merger: Sun Pharma readies new leadership team
Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the organisations.
Mar 12, 2015, 15:10 PM IST
SPARC shares surge 15%; m-cap up by Rs 1,685 cr
Stocks of Sun Pharma Advanced Research Company surged 15 percent Monday after the company received approval from the US health regulator for a New Drug Application (NDA).
Mar 09, 2015, 18:05 PM IST
Sun Pharma to buy GSK's opiates business in Australia
The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment.
Mar 03, 2015, 09:53 AM IST
Suzlon shares end up on buzz of fin security from Shanghvi
Shares of Suzlon Energy today ended nearly 4 percent higher amid reports that Sun Pharma's Dilip Shanghvi will provide as much as Rs 3,800 crore of security for the company to help the wind turbine maker fill orders and return to profit.
Feb 24, 2015, 18:53 PM IST
Sun Pharma Q3 net profit declines 7% to Rs 1,425 crore
Drug major Sun Pharma on Saturday reported 6.92 percent decline in consolidated net profit at Rs 1,425.07 crore for the third quarter ended December 31, 2014-15, saying it was hit by supply constraints.
Feb 14, 2015, 16:14 PM IST
Dilip Shanghvi's mother gifts Sun Pharma shares to his wife
Sun Pharma Managing Director Dilip Shanghvi's mother Kumud S Shanghvi, one of the promoters of Sun Pharma, has gifted nearly 31 lakh shares worth Rs 282 crore to her daughter-in-law Vibha D Shanghvi.
Feb 03, 2015, 21:36 PM IST
Sun Pharma gets US FTC clearance for Ranbaxy acquisition
The early termination of the waiting period under the HSR Act satisfies one of the essential conditions to the closing of the Ranbaxy acquisition, it added.
Feb 02, 2015, 11:14 AM IST
Sun Pharma chief expects Ranbaxy deal to be closed by mid-Feb
Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of health regulators.
Jan 25, 2015, 11:14 AM IST
Ranbaxy Lab, Sun Pharma gain up to 3.5% as CCI clears deal
Sun Pharma and Ranbaxy yesterday got CCI's approval for their long-pending USD 4-billion merger, but with a condition that they will have to modify the deal by divesting seven key products to address monopoly concerns.
Dec 09, 2014, 19:35 PM IST
Ranbaxy Lab, Sun Pharma gain as CCI clears deal
Ranbaxy Lab's stock rose 4 percent to Rs 650.7 at the BSE.
Dec 09, 2014, 13:14 PM IST
Sun Pharma, Ranbaxy to sell 7 products to meet CCI conditions
While approving their USD 4-billion merger, Competition Commission of India (CCI) has asked the two companies to divest seven products to address anti-competitive concerns.
Dec 08, 2014, 20:26 PM IST
CCI clears Sun-Ranbaxy deal with riders; asks to divest 7 products
The approval, which comes within days of clearance from theFIPB, for the deal that was announced in April and would create create India's largest and world's fifth biggest drug-maker.
Dec 08, 2014, 18:23 PM IST
CCI approves Sun Pharma-Ranbaxy deal; creates India's largest pharma co
However, the approval did not come without its share of conditions as the CCI asked the two companies to divest some products as not to affect fair competition in the market.
Dec 08, 2014, 17:49 PM IST
Sun-Ranbaxy deal gets FIPB nod
The Sun Pharma-Ranbaxy transaction would create the country's largest pharmaceutical company.
Dec 01, 2014, 18:39 PM IST
CCI suggests changes to Sun Pharma-Ranbaxy deal
The deal, which CCI has prima-facie found to be in violation of competition norms, was inked in April this year and has been awaiting clearance from the competition watchdog since then.
Dec 01, 2014, 15:56 PM IST
